cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What SURPASS-CVOT trial: For patients with

New blood vessels mean more oxygen and nutrient delivery to the damaged area

Bloating is one of the most reported digestive side effects of tirzepatide

Semaglutide, tirzepatide, and emerging options like retatrutide each offer different benefits, and the right choice varies from person to person.

To understand how we are getting these longer-term effects, we need to study these drugs on a longer time scaleand thats exactly what we did. When the hormone GLP-1 finds a pancreatic beta cell, the ensuing chain of signals, proteins, and gene expression changes that lead to insulin secretion is very well documented

Take it 1015 minutes before training, which is when it is most effective and you can fully benefit from its properties